Remove Food Remove Healthcare Remove Networking Remove Physicians
article thumbnail

U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare

Clarivate

healthcare payers and providers are consolidating at a dizzying clip as they seek to gain market share, increase access to care and secure clinical control to improve health outcomes.

article thumbnail

Engaging Communities through High-Impact Healthcare Sponsorships in the Pharmaceutical Industry 

Pharma Marketing Network

Donating to local healthcare organizations: Pharmaceutical companies can donate money or products to local healthcare organizations to support their work and help improve access to care. Volunteering: Pharmaceutical companies can encourage their employees to volunteer their time to support local healthcare organizations.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharma Marketing: A Guide for Healthcare Companies

Pharma Marketing Network

Pharmaceutical marketing is the process of communicating the benefits of a pharmaceutical product to potential patients and healthcare providers. Direct-to-physician (DTP) advertising: DTP advertising is advertising that is directed to healthcare providers. This can help patients make informed decisions about their healthcare.

article thumbnail

Amgen commits $8m to clinical trial diversity programme

European Pharmaceutical Review

The contribution will enable the programme to reach additional physicians and medical students, further expanding the initiative that aims to extend the reach of clinical trials in underserved patient populations in US communities. The Winn Award Program has so far trained 114 early-stage investigator physicians.

article thumbnail

Healthcare Watch July/August 2022

PM360

Sermo , a physician-first online community, found the tracks at ASCO that oncologists felt were the most transformative to be breast cancer (58%), lung cancer (34%), and developmental therapeutics—molecularly targeted agents and tumor biology (32%). Patient Pages: Stigma Stands in the Way of Migraine Treatment.

article thumbnail

HeartBeam Announces Acquisition of LIVMOR Assets

Legacy MEDSearch

LIVMOR’s technology was commercially deployed within the VA Healthcare System in Dallas, Texas. In February 2022, HeartBeam partnered with LIVMOR to build a HeartBeam-branded version of LIVMOR’s FDA-cleared Halo cloud-based software platform to connect physicians and patients. HeartBeam CEO and Founder.

article thumbnail

Orlucent Receives FDA Breakthrough Device Designation for Handheld Mole Imaging System

Legacy MEDSearch

Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the company’s Orlucent® Skin Fluorescence Imaging System. ” To use the Orlucent system for assessing an atypical lesion, a healthcare professional applies the reagent then uses the imager to capture both white light and fluorescent images. .”

FDA 52